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Prolactin receptor expression by splenocytes from rats in 
various hormonal states 
Abstract. Prolactin (PRL) is mitogenic for lymphocytes iiz vitro, but the responsive- 
ness of lymphocytes depends on the in L ~ I W  hormonal status of the rats from which 
the cells were obtained. Lymphocytes from ovariectomized (OVX) rats, but not 
from rats in oestrus or from male rats, respond to  prolactin; administration of 
oestradiol to OVX rats diminishes the response. In order to determine if a correla- 
tion exists between lymphocyte responsiveness to prolactin and levels of cell surface 
prolactin receptors (PRL-R) expression, the percentage of splenocytes and each 
splenocyte subpopulation expressing surface PRL-R from rats of various hormonal 
states (OVX, oestradiol-injected OVX, oestrus and male) was analysed by single- 
colour and dual-colour flow cytometric analysis. We found that approximately 20% 
of splenocytes expressed surface PRL-R regardless of hormonal states (n= 16). The 
majority (85%)  of PRL-R positive splenocytes were B lymphocytes whereas 11.1% 
and 4.8% of splenocytes expressing the PRL-R were CD4 positive T-helper (Tk,) 
and CD8 positive T-cytotoxic (Tc) lymphocytes, respectively. B lymphocytes also 
stained more brightly than T lymphocytes. This distribution of PRL-R expression 
did not show significant alterations on total splenocytes or TH and T,. lymphocytes 
during various hormonal stages. However, the percentage of PRL-R-positive B 
lymphocytes increased markedly in OVX rats (twofold), compared to rats at oestrus. 
In summary, no correlation was found between the responsiveness to prolactin as a 
mitogen and levels of PRL-R expression by lymphocytes from rats at different 
hormonal states. This result suggests that sex steroid hormones may control 
prolactin responsiveness of lymphocytes by affecting the signal transduction pathway 
through PRL-R rather than by altering the level of the cell surface receptor 
expression. 
Prolactin (PRL) is a member of a family of  polypeptide hormones including growth hormone 
and placental lactogen which probably arose by duplication of an ancestral gene (Niall et al. 
1971). PRL affects a variety of physiological processes in vertebrates such as reproduction, 
lactation. growth and morphogenesis, metabolism, behaviour and immunoregulation (Nicoll 
& Bern 1972). 
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The immunoregulatory function of PRL has been supported by substantial evidence. PRL 
can affect the immune system in vivo and cells of the immune system in vitro. 117 viiw, PRL 
has been reported either to enhance or suppress cellular or humoral immune responses. For 
example, in adult rats, hypophysectomy or bromocriptine treatment caused a lowered 
production of antibody and of adjuvant-induced arthritis (Nagy & Berzci 1978. Bernton et al. 
1988). Administration of PRL restored these responses. In addition, in viva administration of 
PRL appears to regulate DNA synthesis and expression of the c-myc proto-oncogene in 
lymphoid tissue of hypophysectomized rats (Berczi et a/. 1991). 
Evidence from in vitro studies indicates that PRL can affect lymphoid cells directly. A rat 
lymphoma cell line, Nb2, depends on PRL for proliferation (Tanaka et ul. 1980). PRL 
induces the transcription of growth related genes: c-myc, ODC. hsp-70 and p-actin in Nb2 
cells (Yu-Lee 1990). PRL also can regulate interferon regulatory factor (IRF-1) expression in 
lymphocytes (Stevens & Yu-Lee 1992). More recent studies indicated that PRL is mitogenic 
for splenocytes from ovariectomized (OVX) rats (Mukherjee et al. 1990; Viselli & Mastro 
1991). Cells from females in oestrus, from OVX rats injected with oestradiol, or from males 
did not proliferate in response to PRL. However, cells from all groups gave similar responses 
to a polyclonal T-cell mitogen, Con A. From these studies, PRL appears to behave like a 
classical T-cell mitogen in that it causes IL-2 production and IL-2R expression. 
Prolactin exerts its biological effects by binding to its receptor. Prolactin receptor (PRL-R) 
is encoded by a single gene on chromosome 5 .  PRL-R cDNA from rat liver and ovary, rabbit 
mammary gland, human breast, liver tumour ccll lines (review by Kelly et al. 1993) and 
mouse mammary gland (Moore & Oka 1993) have been cloned and sequenced. Two forms 
of PRL-R have been identified in normal rat tissues: long and short forms. The short form 
differs from the long form in length and sequence of the last 30 amino acids in the 
C-terminal region (Boutin et al. 1988, Edery et a/. 1989; Shirota et a/. 1990). The significance 
of the existence of two forms of the PRL-R is not known. In addition to the short and the 
long form, a mutant intermediate form of PRL-R has been found in Nb2 cell line (Ali et al. 
1991). This form of PRL-R is missing 198 amino acid region in cytoplasmic domain. 
Because PRL is a potent mitogen for splenocytes from OVX rats, we believe that there is 
a difference in the splenocytes from animals in different hormonal states (OVX, OVX rats 
injected with oestradiol and oestrus, and male rats). One difference may be at the cellular 
level, i.e. the lymphocyte subpopulation composition may be different or the lymphocytes 
may express more or different receptors. Therefore, the aim of this study was to investigate 
how lymphocyte subpopulations and the expression of cell surface PRL-R on lymphocytes 
change during different hormonal states. Cells treated with antibodies against PRL-R and 
lymphoid specific surface markers were analysed by flow cytometry. 
M A T E R I A L S  A N D  M E T H O D S  
Animals 
Fisher F344 rats (Charles River, Wilmington, MA) were housed in a room maintained at 
20-22°C on a 14 h light, 10 h dark schedule with free access to food and water. Female rats 
were ovariectomized (OVX) at 43 days of age. After 14 days, OVX rats were sacrificed or 
injected with 17-lj-oestradiol in 0.1 ml sesame oil. Two days and 1 day prior to sacrifice, 
animals were administered 0.5 pg and SO pg oestradiol, respectively. Intact females with 4 day 
regular cycle were sacrificed on the day of oestrus. All oestrus females and male rats were 
sacrificed between 57 and 75 days of age. 
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Lymphocyte preparation 
Rats were sacrificed by C 0 2  asphyxiation. Spleens were removed asceptically, placed in dishes 
in sterile Dulbecco's phosphate buffered saline (PBS), pH 7.2, and gently crushed to release 
the lymphocytes from the tissue. Cells were passed through fine wire mesh to remove 
residual connective tissue and briefly suspended in Tris ammonium chloride, pH 7.2, in order 
to lyse erythrocytes. Cells were washed in weak. buffered acid (25 mM sodium acetate in PBS, 
pH 4) to free any ligands from their cell surface receptor, thereby ensuring that epitopes 
recognized by antibodies were free from obstruction. Cells were counted using a haemo- 
cytometer; viability was determined by trypan-blue exclusion. Viability was > 85%. 
Antibodies and staining of splenocytes 
Mouse monoclonal antibodies (IgGI isotypc) used to stain for specific rat leukocyte antigens 
were obtained from Bioproducts for Science (Indianapolis. IN). Anti-rat CD4. anti-rat CD8. 
anti-rat CD5, anti-kappa light chain and anti-IL-2R ?-chain were used at 1/400, ]/BOO, 1/400, 
1/800 and 11400 final dilutions, respectively, following previously published procedures 
(GiineS & Mastro 1996). All leukocyte surface antigen antibodies were detected by flow 
cytometry as log integrated green fluorescence (LIGFL) by using rat anti-mouse IgG 
conjugated to FITC (Jackson Immuno Research Laboratories Inc., West Grove, PA) at  a 
dilution of lil00. Surface PRL-R were detected using the polyclonal antisera (at 1/50 
dilution) to the first 13 amino acids in N terminus of rat PRL-R (Hooper et al. 1993), a gift 
from Dr Kurt Ebner (University of Kansas, Medical Center). Cells expressing PRL-R were 
detected as log integrated yellow fluorescence (LIYFL) by using goat anti-rabbit IgG 
conjugated to PE (Caltag Laboratories, San Francisco, CA) at a dilution of 1/100. Control 
antibodies were used to determine background fluorescence and non-specific binding of 
antibodies. Mouse IgG specific for bovine CDX, an isotype control with irrelevant specificity 
served as a control for leukocyte surface antigens. Cells exhibited I %  to 3% non-immune 
staining. Cells incubated with normal rabbit serum (NRS), which served as a control for 
PRL-R antibody, exhibited 2% to 5% non-immune staining. These background values were 
substructed from experimental values. 
Freshly isolated splenocytes were plated at 1 x 10h cells/well in 96-well v-bottom plates. In 
dual staining experiments, 50 , ~ t l  of anti-rat leukocyte surface antigen antibody and SO PI of 
anti-PRL-R antibody were added concurrently to the wells. Cells were incubated at 4°C for 
25 min and washed twice with PBS (pH 7.2) containing 2% calf serum, 1% goat serum, and 
0.015% azide. Next, 100 pI appropriate secondary antibodies conjugated to either FITC or PE 
were added and incubated with the cells for 25 min in the dark. Cells were washed twice, 
placed in 100 it1 of fixative (1% paraformaldehyde dissolved in PBS) and stored up to 5 days 
at 4% in the dark before the flow cytometric analysis. Prior to analysis, cells were washed 
three times to remove residual fixative. 
Flow cytometric analysis 
Flow cytometric analysis were carried out as described by Viselli & Mastro (1993). Briefly, 
10000 cells per sample were analysed in duplicate by an EPICS 753 Flow Cytometer (Coulter 
Electronics, Hialeah, FL) equipped with two argon ion lasers. The filters used were a 
457-504 nm laser blocking filter and a 550 nm long pass dichronic filter with a 525 nm band 
pass filter for FITC fluorescence and 575 nm band pass filter for PE fluorescence. The laser 
was tuned to 488 nm at 100 mW of power. During data collection, forward angle light scatter 
and 90" light scatter was used to gate on cells to be included in analysis; data were collected 
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in list mode forfnat. For dual-colour experiments, the four quadrants for analysis were 
detined using positive control samples with both FITC and PE. 
Data was Linalysed using the Epics Elite software package. Log integrated fluorescence 
distributions were generated and analysed to determine percentages of cells that were 
positively fluorescent. In dual-colour experiments, dot plots with log intensity yellow 
fluorescence as the vertical axes and log intensity green fluorescence as horizontal axes were 
created. Duplicate samples were averaged. The percentages of positive cells from proper 
control samples, exhibiting non-immune fluorescence, were substracted from the percentages 
of  positive cells. The Macintosh StatView S E +  program was used to determine mean 
values$-SEM. Statview. Fisher PLSD test, was used and significant differences at YS% 
(P=O.O5) and 99%' (P=O.OOX) confidence intervals were determined. 
R E S U L T S  
PRL-R expression by splenocytes 
Cell surface expression of PRL-R was seen on rat splenocytes with antibodies to  cxtracellular 
region of PRL-R along with flow cytomctry. Approximately 20.6f2%1 (meanf SEM; t i =  16) 
of splenocytes expressed PRL-R regardless of the hormonal states of the animals from which 
the spleens were taken. The log intensity fluorescence distribution indicated that most of the 
PRL-R positive lymphocytes stained relatively dimly cornpared to the highly fluorescent 
peaks obtained from the fluorescence distribution of  CD4 positive and CD8 positive lympho- 
cytes (Figure la-c). 
Because splenocyte preparations contain heterogeneous subpopulations of lymphocytes, we 
identified some of these cells. Splenocytes were stained with anti-CD4 for helper T-cells (TH), 
anti-CD8 for cytotoxic T-cells (T,.) and anti-kappa light chain for B-cells. Flow cytometric 
analysis showed that the percentage of each lymphocyte subpopulation in total splenocytes 
was 24.3 f 0.8% CD4 + ; 19.5 f 0.75% CDX + ; and 55.5 $- 0.9% B-cells (mean $- SEM; I?  = 16, 
Table I ) .  
Percentages of lymphocyte subpopulations expressing PRL-R 
Dual-colour flow cytomctric analysis revealed that a greater portion of B lymphocytes 
expressed surface PRL-R (mean, 3 1.5 3%; I Z  = 16) compared to either CD4 + cells (mean, 
Y.8& 1.4%; t i =  16 of CD4 + cells) or CD8+ cells (5.4f 1.2% of CD8+ cells). In other 
words, the average percentage distributions of B-cells, CD4+ cells and CD8-t cells among 
PRL-R positive splenocytes were approximately 8576, 1 1  % and 4.376, respectively (Table I ) .  
This distribution of PRL-R expression among splenocyte subpopulations may be due to the 
observation that the numbers of B lymphocytes in the spleen outnumber both T lymphocyte 
subpopulations. 
Whcn fluorescence distributions of PRL-R expression in each subpopulations were 
compared, B lymphocytes stained more brightly for PRL-R than the T lymphocytes (Figure 
2a-c). The brightly stained PRL-R positive B lymphocytes were more fluorescent than 
PRL-R positive T-cells. The results indicate that more B-cells than T lymphocytes expressed 
PRL-R, and that B lymphocytes also expressed the PRL-R more densely. 
PRL-R expression by splenic lymphocytes from rats at various hormonal stages 
In order to determine if responsiveness to PRL as a mitogen in vitro was related to the 
percentages of splenocytes expressing PRL-R, splenocytcs from rats at different hormonal 
states were subjected to a single-colour and dual-colour flow cytometric analysis. OVX rats, 
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oestradiol-injected OVX rats. intact females at oestrus and males were compared. The 
average percentage of splcnocytes expressing PRL-R from oestrus females was lower than 
that o f  splenocytes from other groups of rats (Table 2). However, there were no significant 
differences in the percentages of  cells expressing PRL-R from animals in the various physio- 
logical stages examined. 
Moreover, the percrntagc o f  each lymphocyte subpopulation expressing PRL-R was also 
investigated in rats at various hormonal states, CD4 +. CD8 + and B lymphocytes of spleno- 
cytes from each group were analysed. Although there were no statistically significant differ- 
cnces in the percentage of  each lymphocyte subpopulation expressing PRL-R during 
different hormonal states, the percentage o f  B lymphocytes expressing surface PRL-R from 
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Log f I u o rescence intensity 
Figure 1. Fluorescent distribution o f  splenocytes stained with antibodies against PRL-R, CD4, or CD8 
and FITC-conjugated secondary antibody. Histograms show the log integrated grcen fluorescence 
intensity 18s. cell size. The average percentages o f  PRL-R+ (a),  CD4+ (b) or CD8+ (c) cells are 
represented in Table 1. 
ClW7 Blxkwcll Science Ltd, Cell ho/ i t i . r . i r / i o , i ,  30. 127-137 
132 H. Giinq ct al. 
Table 1. Surface PRL-R expression on subpopulations of splenic lymphocytes 
Percentage o f  each 
Subpopulations of Percentage of subpopulation Relative brightness 
splenocytes total lymphocytes expressing PRL-R of PRL-R expression 
~~ 
24.3 0.80 
19.5 f 0 . 7  
55.5 fO.9 
9.8 f 1.4 
5.4 & I .2 
3 1.5 k3.1 
Low 
Low 
High 
The percentages of splenocyte subpopulations expressing surface PRL-R was determined by dual- 
colour flow cytometric analysis. Splenocytes were isolated from rats at different hormonal states and 
stained with PRL-R antisera and either anti-CD4, anti-CDX, or anti-kappa light chain (specific for Ti,, 
Tc and B lymphocytes. respectively). The PRL-R was detected using PE conjugated anti-rabbit IgG 
antibody. and the splenocyte subpopulations with FlTC conjugated anti-mouse IgG antibody. The 
relative brightness of PRL-R staining was gauged by the positions of cells in the second quadrant along 
the yellow fluorescence intensity axis o f  dual-colour dot plots. Data represent the mean +SEM 
(n= 16). 
OVX rats was significantly greater (mean 40.3+5%; n = 6 )  than that of B lymphocytes from 
rats in ocstrus (mean 20.1 +3.8%; n=4). In addition, a number of differences among rats 
from different hormonal backgrounds were observed in the percentages of three lymphocyte 
subpopulations in the spleen (Table 2). Male rats had a greater percentage of CD4+ 
lymphocytes (mean 27 25%; ti =3) than OVX (mean 23.1 f 0.3%; n =6) or OVX + E2 rats 
(mean 21.4f2.3%; n=3); fewer CD8+ cells (mean lh.8f2%; n=3) than oestrus females 
(mean 22.0*1.5%; n=4)  more B lymphocytes (mean 59.6+2.9%; n = 3 )  than either OVX or 
oestrus females (mean 54.3 f0.9%; n=6;  and mean 52.5 f0.976; n=4, respectively). Females 
in oestrus were observed to have a greater Percentage of CD4+ lymphocytes (mean 
26.5+ 1.2%; n=4)  than OVX rats (mean 23.1 +0.3%; n = 6 )  or OVX+E2 rats (mean 
21.6f3.9; n=3); fewer B lymphocytes (mean 52.5&0.9%; n=4) than OVX+E2 (57.9f 1.4%; 
n=3) or male rats (mean 59.6f2.976; r1=3) .  
D I S C U S S I O N  
In this study, we investigated how percentages of splenocyte subpopulations and the 
percentage of each subpopulation expressing PRL-R alter during various hormonal stages in 
order to determine if a change in these parameters may be responsible for the PRL respon- 
siveness of splenocytes from OVX rats. We found that approximately 2496, 20% and 567% of 
splenocytes were CD4+, CD8+ and B lymphocytes, respectively. When the percentage of 
each splenocyte subpopulation from rats at different hormonal states was compared, a few 
significant alterations have been observed. First, the Percentage of CD4+ cells from OVX 
rats or from O V X f E 2  rats were significantly less than that of CD4+ cells from oestrus rats 
or from male rats (Table 2). Second, the percentage of CD8+ cells from rats at oestrus was 
statistically greater than that of CD8+ cells from male rats. Finally, the percentage of B-cells 
from male rats was higher than that of B-cells from rats at oestrus or from OVX rats. These 
results indicate that there was no significant alteration in the percentage of CD8+ cells and 
B-cells between rats at oestrus and OVX rats. Based on this finding, we concluded that the 
PRL responsiveness of splenocytes from OVX rats but not from rats at oestrus is not due to 
the alteration of the percentage of lymphocyte subsets, suggesting that a more subtle differ- 
ence must exist between PRL-responsive and PRL-unresponsive splenocytes. Furthermore, it 
seems that a significant decrease in the percentage of CD4+ cells in OVX rats compared to 
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rats at oestrus may not be one of the possibilities for PRL-responsiveness of lymphocytes 
becausc the percentage of CD4+ cells from OVX+E2 was similar to that of CD4+ cells in 
OVX rats. 
A few studies have examined the distribution of surface PRL-R on lymphocyte subpopula- 
tions from rats at different hormonal stages. Therefore, we firstly determined the percentage 
of each splenocyte subset expressing PRL-R, regardless of in viiu hormonal states of the rats. 
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Figure 2. Dual-colour fluorescence dot plot demonstrating the surface membrane expression of PRL-R 
on CD4+ (a), CDX+ (h)  or B- ( c )  cells. Splenocytes were stained with PRL-R antisera and either anti- 
CD4, anti-CD8, o r  anti-kappa light chain. PRL-R positive cells are represented by a log yellow Huores- 
cence intensity distribution. C D 4 + ,  CDX+ or kappa light chain+cells are represented by a log green 
fluorescence intensity distrihution. Quadrants 1 and 2 contain cells expressing surfacc PRL-R; quadrants 
2 and 4 contain cells expressing leukocyte surfacc antigen heing considered; quadrant 2 contains a 
particular phenotype (e.g. CD4 + T-cells) expressing surface PRL-R. Average percentages (ti = 16. 
meanfSEM)  of cells in the dot plot quadrants arc represented in the Table 1 .  
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Table 2. Percentages of splenocytes expressing PRL-R and their distribution among splenic lymphocyte 
subpopulations in rat at various hormonal stages 
Splenocyte 
phenotype 
Hormonal stages 
ovx OVX + E2 Oestrus Male 
PRL-R + (total splenocytes) 
T,, cells (CD4+) 
Ti, cells expressing PRL-R (S) 
Tc cells (CDX+) 
Tc cells expressing PRL-R (%)) 
B-cells (kappa + ) 
B-cells expressing PRL-R (76) 
25.0k4.7 
23.1 k0.3 
11.2*3.1 
19.9 0.4 
5.311.1 
54.3 k0.Y 
40.3 ks.51 
2 1 .h * 3.9 13.6k4.1 
21.4 f2 .3  26.5 * I .?* 
12.7f 1.2 6.1 * 2.0 
1 8 . 7 i  1.4 22.0 f 1.5t 
2.1 f 1.2 4.5 f 2.2 
57.9 f 1.4 52.5 f 0.94 
29.2 f 6.6 20.1 f 3.8 
20.3 * 3.0 
27.1 k 7.OZk 
8.8 * 1.8 
16.8 k 2.0 
4.4 k0.9 
59.6 * 2.99 
30.2 k0.9 
Splenocytcs were isolated from rats in different hormonal stages. OVX rats (n=6) ,  OVX rats 
administered oestradiol (OVX + E2; IZ =3) ,  females in oestrus ( 1 2  =4). and males (ti =3). The splenocytes 
were stained and analysed with dual-colour flow cytometry as in the legend to Table 1. Statistical 
analysis was done using the Fisher PLSD test, and differences at a confidence level of 9S% were 
considered significant. Data represent the mean k SEM. The significant differences among groups were 
shown by different letters. "Different from OVX and OVX + E2; ?different from male; $different from 
OVX+E2 and male; $different from OVX and oestrus; and Tdiffercnt from oestrus. 
Our results show that 10% of CD4+, S%J of CD8+ and 30% of B splenocytes cxpress 
surface PRL-R, and that the majority (85%) of total splenocytes expressing PRL-R are B 
lymphocytes. Similarly, Gagnerault et al. (1993) reported that nearly all B lymphocytes 
express PRL-R and approximately 9S% of B-cells stain brightly for the receptor by using 
biotinylated anti-PRL-R monoclonal antibody US. They also found that approximately SO%) 
of CD4+ and CD8+ lymphocytes express PRL-R and most of these cells stain dimly for the 
receptor. Gala & Shevach (1993) indicated that S g j  of CD4+. 20% of CD8+ and 20%) to 
80% of B lymphocytes express surface PRL-R by using the five monoclonal antibodies t o  
PRL-R, directly conjugated to fluorescein (Okamura et al. 1989). Viselli & Mastro (1993) 
reported a much more even distribution of PRL-R among splenocyte subpopulations using a 
polyclonal antibody, anti-PRL (Bajpai et al. 1991). They found that approximately 25%) of 
CD4+ cells, 25% of CD8+ cells and 205% of B-cells displayed PRL-R. The variability in the 
percentage o f  B or T lymphocytes staining positive for PRL-R among these reports is most 
probably due to different monoclonal or polyclonal antibodies to PRL-R, different species 
and sensitivity of the techniques used in these studies. 
In the present study, the percentage of CD4+ and CDX+ lymphocytes expressing PRL-R 
did not exhibit a significant change during different hormonal states. Based o n  the result of 
Visclli ( I  992). T-cells but not B lymphocytes proliferated after stimulation with PRL. 
Therefore, our finding indicates that there is no correlation between responsiveness to PRL 
as a mitogcn for lymphocytes and levels of surface PRL-R expression. This result is in 
agreement with that of Gala & Shevach (1993) who examined the percentage of lymphocyte 
subsets from intact and OVX BALBic mice and found that the percentage o f  lymphocyte 
subsets (CD4+, CD8+, B-cells) expressing PRL-R did not markedly change in OVX micc. 
Unlike their findings, we observed that the percentage of B lymphocytes expressing PRL-R 
was the greatest in the OVX rats compared to intact females in oestrus (Table 2). 
Both the present study and the studies of others (Viselli & Mastro 1993, Gagnerault et (11. 
1993, Gala & Shevach 1993) indicate that B lymphocytes display cell surface PRL-R. Among 
the lymphocyte subsets expressing surface PRL-R, the percentage of B lymphocytes is higher 
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than that of CD4+ and CD8+ lymphocytes. However. the role of PRL in regulating the 
activity of cach splenocyte subset is not known yet. When splenocytes are stimulated with 
PRL and stained for DNA content with propodium iodide. the CD4+ and CD8+ lympho- 
cytes but not B lymphocytes move beyond G,,/G, and increase in DNA content (Viselli 1992). 
After 96 h of stimulation with PRL, the percentages of CD4+ and CD8+ lymphocytes in 
culture increased signiticantly (Viselli & Mastro 1991). Gala & Shevach (1993) observed that 
in ConA stimulated cultures, the T lymphocytes increase their surface membrane expression 
of PRL-R but B lymphocytes do not. In addition, in ConA stimulated lymphocyte cultures. 
a molecule with prolactin-like bioactivity is secreted (Montgomery rt al. 1987). Because 
ConA is a T-cell mitogen, it was proposed that T-cells secreted the PRL. In a further study, 
T-cells separated from ConA stimulated cultures were shown to express PRL mRNA. These 
data give some clue about the prolactin’s role in regulation of the T lymphocyte activity but 
they do not explain why B lymphocytes express PRL-R. Hartmann et ul. ( 1  989) demonstrated 
that the antisera to prolactin can abrogate the mitogenic response of lymphocytes to both 
ConA and the B-cell mitogen. lipopolysaccharide. Therefore, prolactin appears to have a role 
in regulating B-cell, as well as T-cell, proliferation. However, more experiments need t o  be 
carried out to elucidate the role of prolactin in the B lymphocytes. 
How responsiveness to PRL is linked t o  the  hormonal status of the rat is still unknown but 
therc are possibilities that need to be examined in future studies. For example, Guillaumot 
& Cohen (19Y4) reported that depending o n  the various physiological stages of the rats, 
different molecular forms of PRL-R were observed by “I-oPRL binding studies. Therefore. 
it could be possible that during different hormonal states, a certain molecular form of PRL-R 
may appcar in the spleen and transduce the mitogenic signal o f  PRL to splenocytes. In 
addition, antibody to the long form of PRL-R recognized two different molecular forms (42 
kDa and 84 kDa) of PRL-R in the spleen (GuneS & Mastro 1996), and ovariectomy may 
cause differential expression of these two molecular forms o f  the receptor. In further studies. 
‘”I-oPRL binding experiments as well as Western blot analysis might distinguish among these 
possibilities. 
Both long and short forms of the PRL-R are expressed in the rat. The long form of 
PRL-R is capable of transducing signal f o r  induction of milk gene expression when 
transfectcd into Chinese hamster ovary cells whereas the short form does not (Ali et al. 
1992). Therefore, it is likely that these receptors function differently. If this is the case, the 
circulating steroid hormones could control the expression of both forms of the PRL-R, and 
responsiveness to PRL as a mitogen would correlatc to predominantly expressed form of the 
receptor. Indeed. ovariectomy resulted in a decrease in mRNA levels of both short and long 
forms of the PRL-R in rat brain (Sugiyama ct NI. lYY4). Because effect of hormones on the 
expression of forms of PRL-R may be tissue specific (GuneS 1995), ovariectomy could 
possibly exhibit more different effects o n  the expression level of long and short forms of 
PRL-R in spleen than it does in the brain. 
Alternativcly the levcl o f  PRL-R expression may not be correlated t o  PRL responsiveness 
o f  splcnocytes at all. Recent studies have indicated an association between each PRL-R 
isoform and a src family protein thyrosine kinase (pS9”’”) in NB2 cells (Clevenger & Medaglia 
1994). Prolactin stimulation resultcd in activation of ,fin and proliferation of NB2 cells. In 
addition, JAK family tyrosine kinasc JAK2 have been shown to be associated with PRL-R 
(Rui et (11. 1994). However, the function of thesc protein thyrosine kinases in signal trans- 
duction pathway through PRL-R in order to stimulate lymphocytes to divide is not yet well 
known. Therefore, it is possible that the key to whether lymphocytes are responsive or 
unresponsive to prolactin as a mitogcn lies within the signal transducing network in the cell. 
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Perhaps circulating steroid hormones could preside over whether or not the signal to divide 
is transduced to the nucleus. Elucidation of signal transduction pathway through PRL-R may 
help us understand how hormones affect signal transduction for lymphocyte proliferation 
upon stimulation with PRL. 
In conclusion, the hormonal status of the animal can influence PRL-R expression. Specific- 
ally a greater percentage of B lymphocytes express PRL-R in OVX rats than rats at oestrus. 
However. no correlation was found between the responsiveness to PRL as a mitogen and the 
levels of cell surface PRL-R expression by lymphocytes during different hormonal stages. The 
underlying mechanism for the initial observation that PRL serves as a mitogen for lympho- 
cytes in vitro only in rats of certain hormonal backgrounds has yet to be determined. 
Research to elucidate the signal transduction pathway by PRL-R and how sex steroid 
hormones modulate the signal transduction by PRL-R may reveal the mechanism. Neverthe- 
less, the finding that PRL-R expression can be modulated by hormonal status gives us clues 
for future investigations. 
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